Department of Cardiology, 63650 Military Hospital, Xinjiang, China.
Department of Respirology and Gastroenterology, 63650 Military Hospital, Xinjiang, China.
Pharmacotherapy. 2024 Jul;44(7):539-548. doi: 10.1002/phar.2947. Epub 2024 Jun 20.
To compare the effects of proton pump inhibitor (PPI) and histamine-2 receptor antagonist (H2RA) use on the occurrence of acute kidney injury (AKI) in septic patients at high risk for developing stress ulcers.
Using the Medical Information Mart for Intensive Care IV version 2.2 database, septic patients with high-risk factors for stress ulcers (i.e., shock, coagulopathy, invasive mechanical ventilation, or chronic liver diseases) were included. Exposures included PPIs and H2RAs within 24 h of intensive care unit (ICU) admission or prior to ICU admission. The primary end point was severe sepsis-associated AKI as defined by the Kidney Disease Improving Global Outcomes criteria stage 3 (KDIGO-3). Propensity score matching (PSM) was performed to balance baseline characteristics. Multivariable Cox proportional hazards regression was used to estimate the effect size.
4731 PPI users and 4903 H2RA users were included. After PSM, there were 1785 pairs exposed to PPIs and H2RAs. In the PSM cohort, the cumulative incident KDIGO-3 rate was higher in the PPI group than in the H2RA group (log-rank test, p = 0.009). Regression analyses showed that PPI exposure [adjusted hazard ratio 1.32, 95% confidence interval (CI) 1.11-1.58, p = 0.002] was associated with incident KDIGO-3 compared with H2RA use. This association remained consistent in sensitivity analyses. Additionally, the PPI group had a higher need for kidney replacement therapy compared with the H2RA group (3.6% vs. 2.1%, P = 0.012).
Among septic patients at high risk for developing stress ulcers, PPI exposure was associated with incident KDIGO-3 AKI compared with H2RA use.
比较质子泵抑制剂(PPI)和组胺 2 受体拮抗剂(H2RA)在发生急性肾损伤(AKI)高危的脓毒症患者中的作用。
使用医疗信息市场重症监护 IV 版本 2.2 数据库,纳入高危应激性溃疡(即休克、凝血障碍、有创机械通气或慢性肝病)的脓毒症患者。暴露因素包括 ICU 入院 24 小时内或 ICU 入院前使用的 PPI 和 H2RA。主要终点是符合肾脏疾病改善全球结局标准 3 级(KDIGO-3)的严重脓毒症相关 AKI。采用倾向评分匹配(PSM)来平衡基线特征。采用多变量 Cox 比例风险回归来估计效应大小。
纳入 4731 名 PPI 用户和 4903 名 H2RA 用户。PSM 后,有 1785 对暴露于 PPI 和 H2RA 的患者。在 PSM 队列中,PPI 组的累积 KDIGO-3 发生率高于 H2RA 组(对数秩检验,p=0.009)。回归分析显示,与 H2RA 相比,PPI 暴露[校正风险比 1.32,95%置信区间(CI)1.11-1.58,p=0.002]与 KDIGO-3 事件相关。敏感性分析也显示出这种相关性一致。此外,与 H2RA 组相比,PPI 组需要肾脏替代治疗的比例更高(3.6%比 2.1%,p=0.012)。
在发生应激性溃疡高危的脓毒症患者中,与 H2RA 相比,PPI 暴露与 KDIGO-3 AKI 的发生相关。